ACM
TNDM icon

Altium Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Altium Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-90,000
Closed -$4.05M – 111
2022
Q4 		$4.05M Buy
+90,000
New +$4.07M 2.06% 17
2022
Q2 		– Sell
-50,000
Closed -$5.82M – 140
2022
Q1 		$5.82M Buy
+50,000
New +$5.84M 1.95% 13

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Altium Capital Management's TNDM Position: Q1 2023 in Review

Altium Capital Management sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 90,000 shares — an estimated $4.05M sold.

Altium Capital Management first reported a position in TNDM in Q1 2022 and held it in 2 quarters. The position peaked at $5.82M in Q1 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Altium Capital Management reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Altium Capital Management sold 90,000 Tandem Diabetes Care shares in Q1 2023, an estimated $4.05M.
  • Altium Capital Management first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 2 quarters.
  • Altium Capital Management's Tandem Diabetes Care position peaked at $5.82M in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Altium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.